Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen Completed Phase 3 Trials for Meningococcal Infections / Meningococcal Meningitis / Meningitis Prevention

Indications	Status	Purpose	Phase
DBCOND0032814 (Meningococcal Infections) DBCOND0034253 (Meningococcal Meningitis) DBCOND0014275 (Meningitis)	Completed	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
NCT03077438	Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years	Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae CRM197 protein (DB16712) Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14427) Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14428) Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14429) Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14430)